Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial.
Lancet Diabetes Endocrinol. 2024 Mar;12(3):174-183. doi: 10.1016/S2213-8587(23)00325-X. Epub 2024 Feb 1.
Lancet Diabetes Endocrinol. 2024.
PMID: 38310920
Clinical Trial.
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
King AB, Philis-Tsimikas A, Kilpatrick ES, Langbakke IH, Begtrup K, Vilsbøll T.
King AB, et al. Among authors: langbakke ih.
Diabetes Technol Ther. 2017 Apr;19(4):255-264. doi: 10.1089/dia.2016.0405. Epub 2017 Mar 10.
Diabetes Technol Ther. 2017.
PMID: 28282219
Free PMC article.
Clinical Trial.
Item in Clipboard
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
Rodbard HW, Buse JB, Woo V, Vilsbøll T, Langbakke IH, Kvist K, Gough SC.
Rodbard HW, et al. Among authors: langbakke ih.
Diabetes Obes Metab. 2016 Jan;18(1):40-8. doi: 10.1111/dom.12574. Epub 2015 Nov 5.
Diabetes Obes Metab. 2016.
PMID: 26343931
Free PMC article.
Item in Clipboard
Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).
Buse JB, Vilsbøll T, Thurman J, Blevins TC, Langbakke IH, Bøttcher SG, Rodbard HW; NN9068-3912 (DUAL-II) Trial Investigators.
Buse JB, et al. Among authors: langbakke ih.
Diabetes Care. 2014 Nov;37(11):2926-33. doi: 10.2337/dc14-0785. Epub 2014 Aug 11.
Diabetes Care. 2014.
PMID: 25114296
Clinical Trial.
Item in Clipboard
Pharmacokinetics and pharmacodynamics of growth hormone in patients on chronic haemodialysis compared with matched healthy subjects: an open, nonrandomized, parallel-group trial.
Langbakke IH, Nielsen JN, Skettrup MP, Harper A, Klitgaard T, Weil A, Engelhardt E, Lange M.
Langbakke IH, et al.
Clin Endocrinol (Oxf). 2007 Nov;67(5):776-83. doi: 10.1111/j.1365-2265.2007.02962.x. Epub 2007 Jul 18.
Clin Endocrinol (Oxf). 2007.
PMID: 17634080
Free PMC article.
Item in Clipboard
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ.
Levy JH, et al. Among authors: langbakke ih.
Transfusion. 2006 Jun;46(6):919-33. doi: 10.1111/j.1537-2995.2006.00824.x.
Transfusion. 2006.
PMID: 16734808
Item in Clipboard
Cite
Cite